<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552487</url>
  </required_header>
  <id_info>
    <org_study_id>112/05</org_study_id>
    <nct_id>NCT00552487</nct_id>
  </id_info>
  <brief_title>Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis</brief_title>
  <official_title>Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wuerzburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wuerzburg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether patients with Hashimoto thyroiditis and
      impaired well-being may have a partial secondary adrenocortical insufficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many patients with Hashimoto thyroiditis who are correctly substituted with thyroid hormones
      have an impaired well-being. in some people an isolated ACTH deficiency was found.

      In this study a 1 µg ACTH test is performed to evaluate the adrenocortical function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">July 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum cortisol-peak 30 min after ACTH-stimulation</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum DHEA-peak 30 min. after ACTH-stimulation,DHEA-S, ACTH</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Hashimoto Disease</condition>
  <condition>Adrenal Insufficiency</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>healthy people without Hashimoto disease receive a 1µg ACTH stimulation test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients with Hashimoto disease with well being receive a 1 µg ACTH stimulation test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients with Hashimoto disease an impaired well-being receive a 1 µg ACTH stimulation test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients with Hashimoto disease and negative TPO antibodies receive a 1µg ACTH stimulation test</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>synacthen</intervention_name>
    <description>1 µg synacthen in the vein</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>ACTH</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hashimoto thyroiditis euthyreot thyroid function with levothyroxin therapy written
             informed consent

        Exclusion Criteria:

          -  • hypothyroidism of other origin

               -  pregnancy and lactation

               -  oral contraception

               -  glucocorticoid therapy during the last 2 months

               -  History of malignancy or chronic infections (Hepatitis, HIV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Allolio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wuerzburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wuerzburg, Department of Endocrinology</name>
      <address>
        <city>Wuerzburg</city>
        <state>Bavaria</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2007</study_first_submitted>
  <study_first_submitted_qc>October 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2007</study_first_posted>
  <last_update_submitted>October 31, 2007</last_update_submitted>
  <last_update_submitted_qc>October 31, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2007</last_update_posted>
  <keyword>isolated ACTH deficiency</keyword>
  <keyword>Hashimoto disease</keyword>
  <keyword>Hashimoto thyroiditis</keyword>
  <keyword>autoimmune thyroiditis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenal Insufficiency</mesh_term>
    <mesh_term>Thyroiditis</mesh_term>
    <mesh_term>Hashimoto Disease</mesh_term>
    <mesh_term>Endocrine System Diseases</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

